Delivery Order SPE2DR25D1021-SPE2DR26FNL2J
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 15, 2025, for the supply of Trokendi XR 100 mg capsules (30-count units) with a ceiling value of $2,168.86. This is a firm fixed-price delivery order with no set-aside designation, performed competitively. The order is scheduled for completion by July 16, 2025, with performance to be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of Trokendi XR 100 mg capsules (30-count packages) with a ceiling value of $3,379.08. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is scheduled for completion by September 22, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and will...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Trokendi XR 50 mg capsules (30-count) with a contract value of $3,085.77. This is a firm fixed-price delivery order with no set-aside designation, meaning it was competitively awarded. The order is scheduled for completion by September 18, 2025, and will be fulfilled from AmerisourceBergen's operations in Conshohocken, Pennsylvania. This delivery order is a child contract...
- This delivery order, valued at $4,785.57, awards AmerisourceBergen Drug Corp the supply of Trokendi XR 200 mg capsules (30-count units) under a Firm Fixed Price contract with the Defense Logistics Agency (DLA). The contract, awarded on October 21, 2025, with completion due by October 22, 2025, will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award represents a non-set-aside, competitively awarded delivery order issued under the company's...
- The Defense Logistics Agency awarded a delivery order valued at $11,571.94 to AmerisourceBergen Drug Corp for the supply of Trokendi XR 200 mg capsules (30-count units) under a firm fixed price contract. The delivery order, issued on August 6, 2025, with an ultimate completion date of August 7, 2025, represents a non-set-aside award to the prime contractor. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a major pharmaceutical distributor and critical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on April 30, 2025, for the supply of Trokendi XR 25 mg capsules (30-count) valued at $1,476.35. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The contract is scheduled for completion by May 1, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on June 30, 2025, for the supply of Trokendi XR 100 mg capsules (30-count units) under a firm fixed-price contract valued at $1,915.56. This competitively awarded, non-set-aside delivery order is set for completion by July 1, 2025, with performance to be fulfilled from the contractor's location in Conshohocken, Pennsylvania. The award represents a single delivery order line item supporting federal...
- The Defense Logistics Agency awarded a firm fixed-price delivery order to AmerisourceBergen Drug Corp on May 12, 2025, for the supply of Trokendi XR 100 mg capsules (30-count). The contract ceiling value is $1,304.52, with an ultimate completion date of May 13, 2025. This is a non-set-aside, competitively awarded delivery order that will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of Trokendi XR 100 mg capsules in a quantity of 30 units, with a ceiling value of $3,281.16. This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 23, 2025, and will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania. No set-aside designation was used for this procurement. This delivery order is executed...
- The Defense Logistics Agency awarded a delivery order valued at $1,689.54 to AmerisourceBergen Drug Corp for the supply of Trokendi XR 100 mg capsules (30-count) on July 24, 2025, with completion expected by July 25, 2025. This non-set-aside, firm fixed-price delivery order represents a routine pharmaceutical procurement supporting federal medical supply needs. The award leverages AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX,...
- SPE2DR25D1021Indefinite Delivery Contract
- SPE2DR25D1021-SPE2DR26FNL2JDelivery Order
The Defense Logistics Agency awarded a $4,907.16 delivery order to AmerisourceBergen Drug Corp on October 22, 2025, for the supply of Trokendi XR 100 mg capsules (30-count units), with an ultimate completion date of October 23, 2025. This firm fixed-price delivery order, which represents no set-aside designation, is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract falls under a child delivery order structure, indicating it is issued against a larger indefinite delivery contract vehicle with the Defense Logistics Agency. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen supplies pharmaceutical products and medical commodities across multiple therapeutic domains to support military and veteran healthcare systems. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to fulfill diverse medical supply needs for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through flexible ordering mechanisms.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.9k | 10/22/25 |